Jonathan C Javitt
First SEC filing: Feb. 14, 2023 · Latest: Feb. 14, 2023
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| April 9, 2025 | NRXP | A | 125,000 | · | · | 125,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Dec. 17, 2024 | NRXP | P | 40,000 | $1.17 | $46,800 | 84,634 Direct | +89.62% | Acquired | 140.2% (price as of 2026-10-05) |
| Aug. 23, 2023 | NRXP | P | 100,000 | $0.33 | $33,000 | 446,332 Direct | +28.87% | Acquired | -14.8% (price as of 2026-10-05) |
| Aug. 22, 2023 | NRXP | P | 200,000 | $0.32 | $64,000 | 346,332 Direct | +136.68% | Acquired | -12.2% (price as of 2026-10-05) |
| Dec. 7, 2022 | NRXP | S | 400,000 | $1.00 | $400,000 | 12,899,997 Indirect | -3.01% | Disposed | -71.9% (price as of 2026-10-05) |
| June 1, 2022 | NRXP | P | 100,000 | $58.00 | $5,800,000 | 146,332 Direct | +215.83% | Acquired | -99.5% (price as of 2026-10-05) |
| June 1, 2022 | NRXP | P | 100,000 | $0.58 | $58,000 | 146,332 Direct | +215.83% | Acquired | -51.6% (price as of 2026-10-05) |
| May 24, 2021 | NRXP | A | 1,422,000 | · | · | 1,422,000 Indirect | · | Acquired | (price as of 2026-10-05) |
| May 24, 2021 | NRXP | A | 13,348,997 | · | · | 13,348,997 Indirect | · | Acquired | (price as of 2026-10-05) |
| May 24, 2021 | NRXP | A | 46,332 | · | · | 46,332 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| April 9, 2025 | NRXP | Stock Option (right to buy) | Common Stock | $1.73 | April 9, 2035 | 125,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $575,000 | $250,000 | · | · | · | · | · | $825,000 |
| 2023 | $602,755 | · | · | · | · | · | $27,443 | $630,198 |
| 2021 | $275,000 | · | · | · | · | · | $102,287 | $377,287 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.